Guru Ownership Trend
Guru Analysis for Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $22.65 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $2.78 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 105.6%. Conversely, Steven Cohen reduced exposure by 23.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Anika Therapeutics, Inc. (ANIK)
Major holders include Cliff Asness ($8.19 M), Renaissance Technologies (RenTech) ($7.04 M), Paul Tudor Jones ($334,105). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.09 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.78 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ANIK. The total reported sell value was $1.76 M.
Yes, 1 managers opened new positions in ANIK, and 1 increased their existing holdings. The total reported buy value was $4.54 M.